Smiths Medical announces that its ViaValve Safety I.V. Catheter has been cleared by the Food and Drug Administration (FDA) and can be marketed in the United States. The ViaValve catheter is designed to enhance clinician and patient safety by helping reduce the risk of both blood exposure and needlestick injury and will be available for sale by the end of summer 2012.
The ViaValve Safety I.V. Catheter can help reduce the risk of blood exposure by means of an integrated valve in the catheter hub. The valve provides blood control by impeding the backflow of blood from the patients vein upon initial venipuncture. This helps to prevent the transfer of bloodborne pathogens from patient to caregiver on soiled gloves, clothing, bedding and dressings by maintaining a clean access site. ViaValve Safety I.V. Catheter also helps prevent inadvertent needlesticks, which, each year, affect approximately 800,000 hospital-based healthcare workers in the U.S.
For nearly 20 years, Smiths Medicals Jelco® safety I.V. catheters have provided needlestick protection consistent with legislation driven by the U.S. Needlestick Safety and Prevention ACT and OSHAs bloodborne pathogens standards (29 CFR 1910.1030). FDA 510(k) clearance of ViaValve Safety I.V. Catheter will allow the company to market a catheter that could help advance I.V. catheter safety by establishing an even higher standard of safety with requirements for blood control.
We are pleased to add a solution that helps to reduce bloodborne infections during I.V. starts, says Tommy Johns, vice president of global product management. The ViaValve Safety I.V. Catheter is the latest advancement in I.V. safety, and is built on the proven Jelco® catheter platform that has been a favorite of clinicians for almost two decades. It is our objective to produce innovative medical products with the purpose of promoting patient, clinician and healthcare worker safety while supporting the best possible clinical outcome.
Product(s) described may not be licensed or available for sale in all countries. The ViaValve catheter is FDA 510(k) cleared in the U.S.
Â
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.